Tommy Bramley, SVP of global consulting at Cencora, discusses how broadening acceptance of RWE has a broad impact on launch strategies.
Tommy Bramley
Advertisement
Dr. Tommy Bramley is President of Lash Group.
Articles by Tommy Bramley
Patient support program providers should incorporate new technologies for more effective processes, but this should be matched with empathy, human connectivity and personalized clinical interventions, writes Tommy Bramley.
Advertisement
Latest Updated Articles
Innovation + Human Engagement = Optimal Patient SupportAugust 21st 2019
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $ 2.3 Billion Agreement to Acquire Ajax Therapeutics
2
Moving Cell and Gene Therapy Towards the Future: Q&A with Maher Masoud
3
FDA Approves Caplyta for Prevention of Schizophrenia in Adults
4
FDA Awards Priority Voucher to Compass for Psychedelic Therapy in Treatment-Resistant Depression
5